Novo Nordisk to cap insulin prices in Minnesota settlement

The settlement filed in a New Jersey federal court follows similar settlements last year with Eli Lilly and French drugmaker Sanofi.

All Minnesotans, with or without insurance, can now buy Novo Nordisk’s insulin products for $35 per month for the next five years. Minnesota Attorney General Keith Ellison announced a settlement with Denmark-based pharmaceutical company Novo Nordisk that guarantees this policy.

The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk

Free Trial

Register for free to keep reading.

To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.

  • Unlimited access to industry insights
  • Stay on top of key rules and regulatory changes with our Rules Navigator
  • Ad-free experience with no distractions
  • Regular podcasts from trusted external experts
  • Fresh compliance and regulatory content every day
Register for free Already a member? Sign in